%0 Evaluation Study
%T [Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments)].
%A Xie YM
%A Zhao YB
%A Jiang JJ
%A Chang YP
%A Zhang W
%A Shen H
%A Lu PF
%J Zhongguo Zhong Yao Za Zhi
%V 38
%N 18
%D Sep 2013
%M 24471307
暂无%R 
%X Through consensus, establish a post-marketing scheme and the technical processes to evaluate Chinese medicine's immunotoxicity on a population, as well as its beneficial influences on the immune system. Provide regulations on the collection, storage and transportation of serum samples. This article applies to the post-marketing scientific evaluation of the immunotoxicity of parenterally administered, and for other ways of taking Chinese medicine.